The authors found rare variants in the GABBR2 gene, which was identified with non-Alzheimer’s disease synaptic functioning, reinforcing the notion that short-term NOS inhibition affects synaptic functioning in non-pathological brain aging [52]. This evidence concerns the gene NOS2 and Alzheimer disease.